NCT02960568View on ClinicalTrials.gov

Genetic Variability in CYP2D6 in U.S Active Duty Population

PHASE1CompletedINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

January 8, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

August 31, 2017

Conditions
Pharmacologic Action
Interventions
DRUG

Primaquine

30 mg oral primaquine one time

Trial Locations (1)

20910

WRAIR, Silver Spring

All Listed Sponsors
lead

Walter Reed Army Institute of Research (WRAIR)

FED

NCT02960568 - Genetic Variability in CYP2D6 in U.S Active Duty Population | Biotech Hunter | Biotech Hunter